METHADONE AND MORPHINE FOR THE TREATMENT OF NEONATAL ABSTINENCE SYNDROME: A COMPARISON OF SAFETY AND EFFICACY

I MAQSOOD; GA QAZI; Z HAMAYUN

doi:10.54112/bcsrj.v2023i1.198

Authors

I MAQSOOD Department of Specialized Healthcare & Medical, The Children’s Hospital & The Institute of Child Health Multan, Pakistan
GA QAZI Department of Govt Health Punjab, The Children’s Hospital & The Institute of Child Health Multan, Pakistan
Z HAMAYUN Department of Physiology, Multan Medical and Dental College Multan, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.198

Keywords:

Neonatal Abstinence Syndrome, Methadone, Morphine

Abstract

This study was designed to compare the safety and efficacy of morphine and methadone for treating NAS. A randomized, double-blind study was conducted at The Children’s Hospital & The Institute of Child Health Multan from December 2021 to December 2022. A total of 180 pregnant women were enrolled in the study, of which 114 needed treatment and were randomized (1:1) to receive morphine or methadone. Standardized Finnegan Score (FS)
was used to assess infants every four hours. Methadone alternating with placebo or neonatal diluted morphine was administered to infants every four hours. The primary endpoint of the study was the duration of the hospital stay. Both the methadone and morphine groups had similar risk factors and demographic variables. There was a total of 14 adverse events equally distributed in both groups. After adjusting for the type of opioid used by the mother, it was
found that the mean relative duration of hospital stay was 13% (which corresponds to the difference of 2.8 days) lower in the methadone group compared to morphine. The duration of treatment was 15% (which corresponds to a difference of 2.2 days) lower in the methadone group than in morphine. The median hospital stay with methadone was 15 days compared to 19 days with morphine (P = .005). Based on the results, it can be concluded that for the treatment of NAS, methadone had better short-term outcomes than morphine

Downloads

Download data is not yet available.

References

Buckley, L. A., Salunke, S., Thompson, K., Baer, G., Fegley, D., and Turner, M. A. (2018). Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients. International journal of pharmaceutics 536, 563-569.

Burke, S., and Beckwith, A. M. (2017). Morphine versus methadone treatment for neonatal withdrawal and impact on early infant development. Global pediatric health 4, 2333794X17721128.

Chin Foo, C. A., Dansereau, L. M., Hawes, K., Oliveira, E. L., and Lester, B. M. (2021). Improving the assessment of neonatal abstinence syndrome (NAS). Children 8, 685.

Favara, M. T., Carola, D., Jensen, E., Cook, A., Genen, L., Dysart, K., Greenspan, J. S., and Aghai, Z. H. (2019). Maternal breast milk feeding and length of treatment in infants with neonatal abstinence syndrome. Journal of Perinatology 39, 876-882.

Ghazanfarpour, M., Najafi, M. N., Roozbeh, N., Mashhadi, M. E., Keramat-Roudi, A., Mégarbane, B., Tsatsakis, A., Moghaddam, M. M. M., and Rezaee, R. (2019). Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials. DARU Journal of Pharmaceutical Sciences 27, 423-431.

Hwang, S. S., Weikel, B., Adams, J., Bourque, S. L., Cabrera, J., Griffith, N., Hall, A. M., Scott, J., Smith, D., and Wheeler, C. (2020). The Colorado hospitals substance exposed newborn quality improvement collaborative: standardization of care for opioid-exposed newborns shortens length of stay and reduces number of infants requiring opiate therapy. Hospital Pediatrics 10, 783-791.

Jilani, S. M., Jordan, C. J., Jansson, L. M., and Davis, J. M. (2021). Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review. Journal of Perinatology 41, 1364-1371.

Jones, H. E., and Kraft, W. K. (2019). Analgesia, opioids, and other drug use during pregnancy and neonatal abstinence syndrome. Clinics in Perinatology 46, 349-366.

Kraft, W. K., Adeniyi-Jones, S. C., Chervoneva, I., Greenspan, J. S., Abatemarco, D., Kaltenbach, K., and Ehrlich, M. E. (2017). Buprenorphine for the treatment of the neonatal abstinence syndrome. New England Journal of Medicine 376, 2341-2348.

Kreutzwiser, D., and Tawfic, Q. A. (2020). Methadone for pain management: a pharmacotherapeutic review. CNS drugs 34, 827-839.

Maalouf, F. I., Cooper, W. O., Stratton, S. M., Dudley, J. A., Ko, J., Banerji, A., and Patrick, S. W. (2019). Positive predictive value of administrative data for neonatal abstinence syndrome. Pediatrics 143.

Mangat, A., Schmölzer, G., and Kraft, W. (2019). Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). In "Seminars in Fetal and Neonatal Medicine", Vol. 24, pp. 133-141. Elsevier.

Merhar, S. L., Ounpraseuth, S., Devlin, L. A., Poindexter, B. B., Young, L. W., Berkey, S. D., Crowley, M., Czynski, A. J., Kiefer, A. S., and Whalen, B. L. (2021). Phenobarbital and clonidine as secondary medications for neonatal opioid withdrawal syndrome. Pediatrics 147.

Morrison, T. M., MacMillan, K. D. L., Melvin, P., Singh, R., Murzycki, J., Van Vleet, M. W., Rothstein, R., O’Shea, T. F., Gupta, M., and Schiff, D. M. (2022). Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy. Hospital Pediatrics 12, 530-538.

Patrick, S. W., Barfield, W. D., Poindexter, B. B., Cummings, J., Hand, I., Adams-Chapman, I., Aucott, S. W., Puopolo, K. M., Goldsmith, J. P., and Kaufman, D. (2020). Neonatal opioid withdrawal syndrome. Pediatrics 146.

Sujan, A., Cleary, E., Douglas, E., Aujla, R., Boyars, L., Smith, C., and Guille, C. (2022). A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome. Family Practice 39, 311-315.

Whalen, B. L., Holmes, A. V., and Blythe, S. (2019). Models of care for neonatal abstinence syndrome: what works? In "Seminars in Fetal and Neonatal Medicine", Vol. 24, pp. 121-132. Elsevier.

Young, M. E., Hager, S. J., and Spurlock Jr, D. (2015). Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome. American Journal of Health-System Pharmacy 72, S162-S167.